FOLLOW US

  • facebook
  • twitter
Sat

March 13, 2026

Lannett and Bausch drug price fixing deal

America February 2, 2026

Lannett and Bausch Drug Price Fixing Deal Reaches $17.85M Multistate Settlement

In a sweeping move spanning nearly every corner of the country, Lannett and Bausch drug price fixing deal will cost…

By Rihem Akkouche

Novartis Buy Avidity Biosciences

America October 27, 2025

Novartis to Buy Avidity Biosciences in $12 Billion Deal

In a bold step that cements its place at the forefront of genetic medicine, Novartis AG announced Sunday that it…

By Rihem Akkouche

Novartis, Monte Rosa $5.7B Deal

America September 15, 2025

Novartis, Monte Rosa $5.7B Deal Targets Immune Diseases

In a bold wager on next-generation drug discovery, Novartis, Monte Rosa $5.7B Deal is set to reshape the landscape of…

By Rihem Akkouche

Novartis To Acquire Tourmaline Bio

America September 9, 2025

Novartis To Acquire Tourmaline Bio in $1.4B Deal to Boost Heart Drug Pipeline

Novartis AG said Tuesday it has agreed to acquire Tourmaline Bio Inc. in a $1.4 billion all-cash deal, a bold…

By Rihem Akkouche

Novartis To Buy Anthos

America February 11, 2025

Novartis To Buy Anthos For Up To $3.1B

Novartis AG announced Tuesday that it will acquire Anthos Therapeutics Inc. in a deal worth up to $3.1 billion, a…

By Rihem Akkouche

Novartis to Acquire Mariana for $1.75B

America May 2, 2024

Novartis to Acquire Mariana for $1.75B

In a significant expansion of its healthcare empire, Novartis AG announced on Thursday its plans to acquire U.S.-based Mariana Oncology.…

By Rihem Akkouche

Novartis to Buy MorphoSys In €2.7B Deal

America February 6, 2024

Novartis to Buy MorphoSys In €2.7B Deal

In a strategic move to bolster its oncology treatment options, Novartis AG, the Swiss pharmaceutical juggernaut, has inked a monumental…

By Rihem Akkouche

Novartis Can't Dodge Sales Rep's Gender Bias Suit

America November 13, 2023

Novartis Can’t Dodge Sales Rep’s Gender Bias Suit

In a courtroom showdown echoing the resilience of justice, a Georgia federal judge defiantly refused to grant Novartis Pharmaceuticals Corp.’s…

By Rihem Akkouche

novartis

Business June 29, 2020

Novartis to pay $346 million to settle U.S. charges over alleged FCPA violations

Novartis AG, a global pharmaceutical company based in Switzerland, reached an out-of-court settlement with U.S. regulators to resolve all pending…

By Marivic Cabural Summers

Signup for the USA Herald
exclusive Newsletter